NCT06268613
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06268613
Title A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Samsung Bioepis Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries TUR | POL | ESP

Facility Status City State Zip Country Details
SB Investigative Site Gdansk Poland Details
SB Investigative Site Otwock Poland Details
SB Investigative Site Ansan South Korea Details
SB Investigative Site Busan South Korea Details
SB Investigative Site Daegu South Korea Details
SB Investigative Site Hwasun South Korea Details
SB Investigative Site Incheon South Korea Details
SB Investigative Site Jinju South Korea Details
SB Investigative Site Seongnam South Korea Details
SB Investigative Site 3 Seoul South Korea Details
SB Investigative Site 4 Seoul South Korea Details
SB Investigative Site 5 Seoul South Korea Details
SB Investigative Site 6 Seoul South Korea Details
SB Investigative Site 1 Suwon South Korea Details
SB Investigative Site 2 Suwon South Korea Details
SB Investigative Site Ulsan South Korea Details
SB Investigative Site A Coruña Santiago de Compostela Spain Details
SB Investigative Site Jaén Spain Details
SB Investigative Site Málaga Spain Details
SB Investigative Site Adana Turkey (Türkiye) Details
SB Investigative Site 1 Ankara Turkey (Türkiye) Details
SB Investigative Site 2 Ankara Turkey (Türkiye) Details
SB Investigative Site Istanbul Turkey (Türkiye) Details
SB Investigative Site Izmir Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field